-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cinanserin
Category | SARS-CoV |
CAS | 1166-34-3 |
Description | Cinanserin is a 5-HT2A and 5-HT2C receptor antagonist. |
Product Information
Synonyms | CINANSERIN;1166-34-3;Cinanserine;Cinanserin [INN];Cinanserina;Cinanserinum;33464-86-7;KI6J9OY7A3;CHEMBL18786;(E)-N-[2-[3-(dimethylamino)propylsulfanyl]phenyl]-3-phenylprop-2-enamide;2-Propenamide, N-(2-((3-(dimethylamino)propyl)thio)phenyl)-3-phenyl-;(2E)-N-(2-{[3-(dimethylamino)propyl]sulfanyl}phenyl)-3-phenylprop-2-enamide;NCGC00024599-02;DTXCID5025653;N-(2-((3-(Dimethylamino)propyl)thio)phenyl)cinnamamide;N-(2-((3-(Dimethylamino)propyl)thio)phenyl)-3-phenylacrylamide;Cinanserine [INN-French];Cinanserinum [INN-Latin];Cinanserina [INN-Spanish];CAS-1166-34-3;UNII-KI6J9OY7A3;DTXSID7045653;N-[2-[[3-(Dimethylamino)propyl]thio]phenyl]-3-phenyl-2-propenamide; 2'-[[3-(Dimethylamino)propyl]thio]cinnamanilide; Cinanserin; Cinanserine; 2'-[[3-(Dimethylamino)propyl]thio]-cinnamanilide;SQ 16167;Biomol-NT_000092;2'-((3-Dimethylaminopropyl)thio)cinnamanilide;SCHEMBL571561;BPBio1_001097;CHEBI:92281;DTXSID30859588;CHEBI:145999;RSUVYMGADVXGOU-BUHFOSPRSA-N;Cinnamanilide, 2'-((3-(dimethylamino)propyl)thio)-, (E)-;HMS2090H06;Tox21_110911;BDBM50016900;Tox21_110911_1;NCGC00024599-03;NCGC00024599-04;AB00640020-06;EN300-21037753;L000903;J-003464;Q2972695;BRD-K15522385-003-01-0;BRD-K40901640-001-01-0;BRD-K40901640-003-01-6;N-(2-(3-(dimethylamino)propylthio)phenyl)cinnamamide;2'-((3-(DIMETHYLAMINO)PROPYL)THIO)CINNAMANILIDE;Z2311575442;N-[2-(3-Dimethylamino-propylsulfanyl)-phenyl]-3-phenyl-acrylamide;(2E)-N-(2-{[3-(Dimethylamino)propyl]sulfanyl}phenyl)-3-phenylacrylamide;(E)-N-[2-(3-Dimethylamino-propylsulfanyl)-phenyl]-3-phenyl-acrylamide;N-[2-(3-Dimethylamino-propylsulfanyl)-phenyl]-3-phenyl-acrylamide (cinanserin);N-[2-(3-Dimethylamino-propylsulfanyl)-phenyl]-3-phenyl-acrylamide(Cinanserin); |
IUPAC Name | (E)-N-[2-[3-(dimethylamino)propylsulfanyl]phenyl]-3-phenylprop-2-enamide |
Molecular Weight | 340.48 |
Molecular Formula | C20H24N2OS |
Canonical SMILES | O=C(NC1=CC=CC=C1SCCCN(C)C)/C=C/C2=CC=CC=C2 |
InChI | InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+ |
InChIKey | RSUVYMGADVXGOU-BUHFOSPRSA-N |
Purity | >99 % |
Appearance | Off-white solid |
Application | Serotonin Antagonists |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |